Supernus Pharmaceuticals Inc (SUPN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

9715 KEY WEST AVENUE ROCKVILLE, MD 20850

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.

Data as of 2020-08-09
Market Cap1.213 Billion Shares Outstanding52.539 Million Avg 30-day Volume459.821 Thousand
P/E Ratio10.6 Dividend Yield EPS2.17
Price/Sales4.075 Price cash flow ratio10.4 Price free cash flow ratio14.2
Book Value11.67 Price to Tangible Book2.06 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.23863
BETA1.52031 52-week High/Low29.81 / 13.12 Stddev0.130872
View SEC Filings from SUPN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 3 (0.2%)
13F Filers holding this stock: 201 61 (3.99%)
Aggregate 13F shares on 03/31/2020: 48.405 Million 21 Million
Aggregate 13F shares on 12/31/2019: 51.287 Million 21.164 Million
Percent change: -5.62% -0.78%
Funds creating new positions: 24 10
Funds Adding to an existing position: 66 19
Funds closing out their position: 47 19
Funds reducing their position: 84 25
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SUPN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SUPN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

920 total shares from 1 transactions

Exercise Derivative Conversion (M)

8.8 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BASKETT FOREST

  • 10% Owner
5,817,366 2020-08-07 0

SANDELL SCOTT D

  • Director
  • 10% Owner
5,684,109 2020-08-07 0

GEMAYEL GEORGES

  • Director
14,090 2020-08-05 1

KHATTAR JACK A. PRESIDENT, CEO

  • Officer
  • Director
1,578,916 2020-07-27 6

MATUSHANSKY IGOR CHIEF MEDICAL OFFICER

  • Officer
56,134 2020-07-20 0

HUDSON FREDERICK M.

  • Director
18,041 2020-07-13 2

LENGAUER CHRISTOPH

  • Director
0 2020-06-18 0

BIGHAM MICHAEL

  • Director
5,000 2020-06-03 0

BARRIS PETER J

  • Director
6,420 2020-05-27 0

PATRICK GREGORY S SR.VP, CHIEF FINANCIAL OFFICER

  • Officer
46,057 2020-05-20 3

BHATT PADMANABH P. SR. VP OF IP, CSO

  • Officer
0 2020-02-21 1

NEWHALL CHARLES W III

  • Director
97,509 2020-02-21 1

MARTIN TAMI TILLOTSON SR. V.P., REGULATORY AFFAIRS

  • Officer
85,279 2020-02-21 2

SIEBERT JOHN M

  • Director
60,953 2020-02-21 1

SCHWABE STEFAN K.F. EXECUTIVE VICE PRESIDENT & CMO

  • Officer
2,772 2020-02-21 1

BARLOW CARROLEE

  • Director
5,211 2020-02-21 1

MOTTOLA FRANK SR VP, QUALITY, GMP OPER. & IT

  • Officer
6,242 2020-02-21 2

BARRETT M JAMES

  • Director
0 2019-05-30 0

PINSCHEWER DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-04-17 0

VAUGHN VICTOR SR. VP OF SALES & MARKETING

  • Officer
9,344 2018-04-18 0

BRYAN JONES W. SR. VICE PRES., BD & LICENSING

  • Officer
No longer subject to file 2018-02-13 0

NUERGE WILLIAM A.

  • Director
23,750 2017-06-13 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

NEW ENTERPRISE ASSOCIATES 11 LP

  • 10% Owner
No longer subject to file 2015-11-11 0

NEA PARTNERS 11 LP

  • 10% Owner
No longer subject to file 2015-11-11 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

ORBIMED CAPITAL GP II LLC

  • 10% Owner
No longer subject to file 2013-02-12 0

NEW ENTERPRISE ASSOCIATES 11 LP

NEA PARTNERS 11 LP

NEA 11 GP, LLC

BARRIS PETER J

BASKETT FOREST

DRANT RYAN D

KOLLURI KRISHNA KITTU

KRAMLICH C RICHARD

PERRY MARK W

SANDELL SCOTT D

  • 10% Owner
10,641,250 2012-05-04 0

SHEFFERY MICHAEL B

  • Director
6,099,996 2012-05-04 0

ABINGWORTH MANAGEMENT LTD

  • 10% Owner
3,600,000 2012-05-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

2020-07-27 A 15,625 a 506,466 1,578,916.00 direct

HUDSON FREDERICK M. - Director

2020-07-13 S 920 $24.44 d 18,041 18,041.00 direct yes

HUDSON FREDERICK M. - Director

2020-07-13 M 8,750 $2.56 a 18,961 18,041.00 direct yes

HUDSON FREDERICK M. - Director

2020-07-13 M 8,750 d 0 18,041.00 direct yes

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

2020-07-10 A 15,625 a 490,841 1,563,291.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments